Background
==========

Cytochrome P450 (CYP) genes refer to such genes that encode a superfamily of iron-containing hemoproteins with a maximum absorption spectrum near 450 nm, often characterized by conserved Cys residue in hydrophobic pocket(s) \[[@B1]\]. Most of the ORFs of CYP have three distinct characteristics used often for their identification and analysis, i.e., the I-helix of putative CYPs (a highly conserved threonine involved in oxygen activation), the conserved EXXR motif located in the K-helix and the cytochrome P450 cysteine heme-iron ligand signature motif (GXXXCXG, there are exceptions) \[[@B2]\]. According to a widely-accepted taxonomy, CYPs within a family share more than 40% amino acid identity and members of subfamilies share more than 55% amino acid identity \[[@B3]\]. Occasionally, the decision to accept a sequence in a known family depends greatly on how it clusters on a tree, not so much on the absolute amino acid identity \[[@B4]\].

CYPs have been confirmed existing in all eukaryotic (human, animals, plants, fungi, etc.) and prokaryotic organisms (bacteria, archaea, and even in viruse) \[[@B5]-[@B8]\]. They often are monooxygenases involved in oxidation of a range of endogenous compounds, such as cholesterol, lipids and steroidal hormones, as well as xenobiotics such as drugs and toxic chemicals in environment \[[@B9]-[@B11]\]. CYPs catalyse diverse reactions, including C-H hydroxylation, epoxidation, hetero-atom oxidation, aromatic ring oxidation and dealkylation \[[@B11]-[@B13]\]. In the catalytic reaction process of P450 monooxygenase, one atom of O~2~ is inserted into substrate while the other is reduced to H~2~O. CYP genes responsible for secondary metabolism are often laid in antibiotic biosynthetic gene clusters to catalyze stereo- and region- specific reaction of substrates to related derivatives.

The biotransforming capabilities of bacterial CYPs have been widely elucidated. P450soy (CYP105D1) from *Streptomyces griseus* was involved in the degradation of a diverse array of complex agrochemicals and environmental pollutants \[[@B14]\]. CYP105C1 from *Actinomycete* spp. had the ability to transform benanomicin A into two derivatives, 10-hydroxybenanomicin A and 11-O-demethylbenanomicin \[[@B15]\]. The functions of related CYP107 family members have been reported. CYP107E from *Micromonospora griseorubida* was found to govern the hydroxylation and epoxidization in mycinamicin biosynthesis \[[@B16]\], P450 Terf (107 L) from *Streptomyces platensis* to catalyze hydroxylation of terfenadine \[[@B17]\] and hydroxylase PikC (107 L1) of *Streptomyces venezuelae* to convert narbomycin to picromycin \[[@B18]\]. CYP124 of *Mycobacterium tuberculosis* demonstrated omega-hydroxylase activity of relevant methyl-branched lipids \[[@B19]\]. YbdT (CYP152A) of *Bacillus subtilis* was involved in fatty acid beta-hydroxylation \[[@B20]\]. CYP154 of *Nocardia farcinica* IFM10152 had the functions of the O-dealkylation and ortho-hydroxylation of formononetin \[[@B21]\] and 154H1 from *Clostridium acetobutylicum* performed biocatalytic reactions with different aliphatic and aromatic substrates \[[@B22]\].

Genome sequencing is an effective way to predict and annotate all the possible CYPs genes in an organism. *Streptomyces coelicolor* A3 (2), a typical strain which is often used for the study of physiological function and antibiotic production, is the first *Streptomyces* species sequenced in 2001. Its linear chromosome is 8.7 Mb \[[@B23]\] which contains 7825 open reading frames (ORFs) with 18 putative CYPs \[[@B24]\]. *S. avermitilis*, known for producing the antiparasitic agent avermectin, contains 7600 ORFs with 33 putative CYPs in the 9 Mb chromosomes \[[@B25],[@B26]\]. The genome of *Streptomyces peucetius* ATCC27592 with the size of 8.7 Mb contains 19 putative CYPs \[[@B27]\].

*S. virginiae* IBL14, isolated from activated sludge for treatment of waste from a steroidal drug factory, is an effective degradative strain of various steroidal compounds, including progesterone, isotestosterone, dihydrotestosterone, hydrocortisone, cholesterol and ostrone \[[@B28]\]. To comprehensively understand the function of CYPs of *S. virginiae* IBL14 in degradation and biotransformation of diosgenin, the whole genome sequencing of *S. virginiae* IBL14 isolated by our lab was carried out for the first time. Using *in silico* technology, we predict and annotate all of the putative CYPs of *S. virginiae* IBL14 and analyze these CYPs evolutionarily and functionally via comparison with those of other *Streptomyces* species. Furthermore, functions and characteristics of CYP genes *svh*01 and CYP *svu*022 in this strain are experimentally identified and analyzed.

Results and discussion
======================

Genome sequencing and CYPs in *S. virginiae* IBL14
--------------------------------------------------

By *in silico* analysis of newly-sequenced *S. virginiae* IBL14 8.0 Mb genome, 8288 ORFs are identified and the total GC content exceeds 70%. The annotated results via Rpsblast display that there are a total of 33 putative CYPs in the genome of this strain IBL14, contributing to approximately 0.4% of all the coding sequences. The number of CYPs is identical to that in *S. avermitili* and almost two times as that in *S. coelicolor* A3(2) and *S. peucetius* ATCC27952 (18 and 19 CYPs, respectively). Such high level of CYP diversity suggests the high diversity of the secondary metabolism pathways in *S. virginiae* IBL14.

The 32 out of 33 putative CYPs of *S. virginiae* IBL14 belong to 13 previously-reported CYP families, i.e., 105 (5), 107 (11), 121 (1), 124 (1), 147 (1), 152 (1), 154 (1), 157 (2), 185 (1), 191 (3), 197 (4), 247(1) and another to an unknown family, as shown in Table [1](#T1){ref-type="table"}. Among the all, the CYP121A (*Svu*018), CYP124 (*Svu*19), CYP147 (*Svu*020), CYP152 (*Svu*021), CYP154H (*Svu*022), CYP157 (*Svu*023-024), CYP185 (*Svu*025), CYP191 (*Svu*26-28), CYP197 (*Svu*017,029-031) and CYP247 (*Svu*032) are firstly reported in *S. virginiae*, and especially, CYP107M, CYP185A and CYP247A have been found rarely in *Streptomycete* spp. The *Svu*025, *Svu*026 and *Svu*029 have lower identity with other family members (\<50%) while others show more than 63% identity to CYPs of other organisms. It's worth noting that the *Svu*001 presumably belongs to a new CYP family since no close homologue is found in Genbank except that in *Streptomyces sp.* Mg1 with 66% identity.

###### 

**Putative cytochrome P450s in*S. virginiae*IBL14 with their closest homologs**

  **ID**^**a**^                                            **Size**^**b**^   **Best matches in the database**                                         
  -------------------------------------------------------- ----------------- ---------------------------------------- -------------- --------- ------ -----
  Svu001                                                   464               *Streptomyces sp*. Mg1                   ZP_05001937    new       598    66
  *Photobacterium profundum* 3TCK                          ZP_01217946                                                113            25               
  Svu002                                                   361               *Streptomyces virginiae*                 ABR68806       105 L     134    100
  *Streptomyces clavuligerus* ATCC 27064                   ZP_06769587                                                93.2           66               
  Svu003                                                   439               *Streptomyces venezuelae* ATCC 10712     CCA59424       105C      608    77
  *Streptomyces cattleya* NRRL 8057                        YP_004920090      105C                                     553            70               
  Svu004                                                   398               *Streptomyces virginiae*                 ABR68806       105 L     794    99
  *Streptomyces sp*. ACT50-5                               BAG16627                                                   529            69               
  Svu005                                                   400               *Streptomyces sp*. C                     ZP_07285089    105D      595    74
  *Streptomyces avermitilis* MA-4680                       BAC75180          105D7                                    529            69               
  Svh01                                                    399               *Streptomyces virginiae*                 ABR68805       105C1     797    99
  *Streptomyces viridochromogenes* DSM 40736               ZP_07307444       105                                      703            87               
  Svu006                                                   403               *Streptomyces virginiae*                 ABR68807       107 L14   713    99
  *Streptomyces sp*. C                                     ZP_07284721       107 L14                                  611            87               
  Svu007                                                   351               *Streptomyces sp*. C                     ZP_07290554    107E      609    87
  *Streptomyces violaceusniger* Tu 4113                    YP_004815015                                               540            77               
  Svu008                                                   406               *Streptomyces sp*. C                     ZP_07285026    107 L14   604    77
  *Streptomyces sp*. Mg1                                   ZP_04997607       107 L14                                  584            76               
  Svu009                                                   415               *Streptomyces sp*. C                     ZP_07286517    107 L     727    85
  *Streptomyces sp*. Mg1                                   ZP_04999247       107 L                                    484            59               
  Svu010                                                   396               *Streptomyces sp*. Mg1                   ZP_04997607    107 L14   578    74
  *Streptomyces sp*. C                                     ZP_07285026       107 L14                                  556            72               
  Svu011                                                   405               *Streptomyces sp*. C                     ZP_07287693    107 L     728    91
  *Streptomyces clavuligerus* ATCC 27064                   ZP_05005324       107 L                                    601            75               
  Svu012                                                   430               *Streptomyces sp*. C                     ZP_07287209    107 L     808    92
  *Streptomyces sp*. Mg1                                   ZP_05000207       107 L                                    780            91               
  Svu013                                                   396               *Streptomyces sp*. C                     ZP_07287353    107 L     578    75
  *Streptomyces hygroscopicus subsp*. jinggangensis 5008   AEY86095                                                   383            54               
  Svu014                                                   395               *Streptomyces sviceus* ATCC 29083        ZP_06921933    107 L     961    80
  *Streptomyces venezuelae* ATCC 10712                     CCA53921          107 L                                    549            79               
  Svu015                                                   406               *Streptomyces sp*. Mg1                   ZP_05001939    107 L     667    80
  *Streptomyces scabiei* 87.22                             YP_003488837      107 L                                    640            77               
  Svu016                                                   406               *Amycolatopsis editerranei* U32          YP_003767608   107 M     482    63
  *Actinomadura hibisc*                                    BAA23153                                                   387            55               
  Svu017                                                   368               *Streptomyces avermitilis* MA-4680       NP_823237      197A1     436    64
  *Streptomyces scabiei* 87.22                             YP_003487606                                               389            59               
  Svu018                                                   393               *Streptomyces venezuelae* ATCC 10712     CCA55152       121A      509    67
  *Mycobacterium tuberculosis* 02_1987                     ZP_06504929       121A                                     464            57               
  Svu019                                                   421               *Streptomyces sp*. C                     ZP_07287311    124B      782    94
  *Streptomyces pristinaespiralis* ATCC 25486              ZP_06909795       124B                                     566            70               
  Svu020                                                   416               *Streptomyces sp*. C                     ZP_07289557    147A      731    91
  *Streptomyces peucetius* ATCC 27952                      CAE53704          147A                                     667            79               
  Svu021                                                   421               *Streptomyces sp*. C                     ZP_07290439    152A      515    71
  *Streptomyces sp*. SirexAA-E                             YP_004806454      152A                                     429            58               
  Svu022                                                   412               *Streptomyces sp*. Mg1                   ZP_05002011    154H      742    91
  *Streptomyces sp*. SirexAA-E                             YP_004804189      154H                                     666            83               
  Svu023                                                   409               *Streptomyces sp*. C                     ZP_07285064    157A      773    93
  *Streptomyces sp*. Mg1                                   ZP_05002010       157A                                     734            88               
  Svu024                                                   450               *Streptomyces sp*. Mg1                   ZP_05002596    157C      723    82
  *Streptomyces hygroscopicus* ATCC 53653                  ZP_07300920       157C                                     574            64               
  Svu025                                                   89                *Streptomyces tubercidicus*              AAT45286       185A1     85.9   47
  *Actinosynnema mirum* DSM 43827                          YP_003102184      185A                                     84.7           51               
  Svu026                                                   409               *Streptomyces violaceusniger* Tu 4113    YP_004813101   191A      313    44
  *Rhodococcus opacus* B4                                  YP_002781958                                               300            43               
  Svu027                                                   398               *Streptomyces sp*. C                     ZP_07286547    191A      756    92
  *Streptomyces sp*. Mg1                                   ZP_04998169       191A                                     733            89               
  Svu028                                                   446               *Streptomyces sp*. Mg1                   ZP_04997583    191A      699    88
  *Streptomyces sp*. C                                     ZP_07290135       191A                                     692            90               
  Svu029                                                   476               *Singulisphaera acidiphila* DSM 18658    ZP_09568426    197A      199    33
  *Streptomyces roseosporus* NRRL 11379                    ZP_04712663       197A                                     191            32               
  Svu030                                                   447               *Streptomyces sp*. C                     ZP_07289871    197B      713    82
  *Streptomyces sp*. Mg1                                   ZP_05001362       197B                                     680            77               
  Svu031                                                   710               *Streptomyces sp*. C                     ZP_07284739    197B      353    79
  *Streptomyces clavuligerus* ATCC 27064                   ZP_05006237                                                350            55               
  Svu032                                                   416               *Streptomyces flavogriseus* ATCC 33331   YP_004921083   247A      693    81
  *Frankia alni* ACN14a                                    YP_712777         247A                                     573            70               

^a^ The name of the putative CYPs in *S. virginiae* IBL14.

^b^ Amino acid number of putative CYPs.

^c^ Closest homologs in Genbank and the family classification of CYPs searched in CYPED.

^d^ Number of amino acid overlap, which exceeds the protein size, is due to the introduction of gaps during BLAST comparison.

^e^ The highest percent identity for a set of aligned segments to the same subject sequence.

Features of CYPs from *S. virginiae* IBL14
------------------------------------------

Table [2](#T2){ref-type="table"} displays the three characteristic motifs of CYPs of *S. virginiae* IBL14. The critical residues are highlighted with bold fonts, which are threonine (T) in GXXTT motif of I-helix, glutamic acid (E) and arginine (R) in EXXR motif of K-helix and cysteine (C) in the GXXXCXG heme-binding domain signature, respectively.

###### 

**A comparison of the conserved domain of putative CYPs in*S. virginiae*IBL14 with those of the same (sub)family in CYPED using ClustalW**

  **ID**   **I-helix**           **K-helix**              **Heme binding motif**             **Accession numbers**
  -------- --------------------- ------------------------ ---------------------------------- -----------------------
  Svu001   Unidentified          **E**^335^TL**R**^338^   F^403^LPFGAGPRH**C**VG^415^        JX119062
  Svu002   Unidentified          Unidentified             L^297^RVGVDRRL**C**CG^308^          
  Svu003   G^276^LD**T**T^280^   **E**^314^LL**R**^317^   H^375^LGFGHGIHQ**C**LG^387^        JX119063
  Svu004   G^237^HE**T**T^241^   **E**^275^SL**R**^278^   H^337^LGFGHGIHQ**C**LG^349^        JX119064
  Svu005   G^247^HE**T**T^251^   **E**^285^LM**R**^288^   H^346^LAFGFGIHQ**C**LG^358^        JX119065
  Svh01    G^235^FD**T**T^239^   **E**^273^LL**R**^276^   H^334^LAFSHGIHQ**C**LG^346^        EF646279
  Svu006   G^277^HE**T**T^281^   **E**^315^ML**R**^318^   H^377^IAFGHGLHY**C**LG^389^        JX119066
  Svu007   G^238^HE**T**T^342^   **E**^276^LL**R**^279^   H^339^LGFGHGVHH**C**LG^351^        JX119067
  Svu008   G^236^HE**T**T^240^   **E**^275^ML**R**^278^   H^337^LAFGHGLHF**C**IG^349^        JX119068
  Svu009   G^236^HK**T**T^240^   **E**^274^MQ**R**^277^   H^338^LGFGYGAHY**C**LG^350^        JX119069
  Svu010   G^234^HE**T**T^238^   **E**^273^ML**R**^276^   H^335^LAFGHGIHF**C**IG^347^        JX119070
  Svu011   G^242^HEAT^246^       **E**^285^LM**R**^288^   H^346^LTFGAGIHY**C**LG^358^        JX119071
  Svu012   G^259^FE**T**T^263^   **E**^302^LL**R**^305^   H^364^LGYGHGIHY**C**LG^376^        JX119072
  Svu013   G^237^SE**T**V^241^   **E**^275^LF**R**^278^   H^337^LALGHGVHY**C**LG^349^        JX119073
  Svu014   G^234^HE**T**T^238^   **E**^272^LL**R**^275^   H^334^LAFGHGVHR**C**LG^346^        JX119074
  Svu015   F^247^AP**T**T^251^   **E**^285^VV**R**^288^   Q^347^LSFGIGVHS**C**LG^359^        JX119075
  Svu016   G^244^YH**T**T^248^   **E**^282^AL**R**^285^   H^345^LAFGAGIHF**C**LG^357^        JX119076
  Svu017   G^207^FL**T**T^211^   **E**^245^GL**R**^248^   H^307^VAFGYGPHA**C**PG^319^        JX119077
  Svu018   G^231^VIST^235^       **E**^269^LL**R**^272^   H^332^FSFGGGSHY**C**PA^344^        JX119078
  Svu019   G^256^VE**T**T^260^   **E**^295^MI**R**^298^   H^356^LGFGGGGPHF**C**LG^369^       JX119079
  Svu020   G^251^HE**T**T^255^   **E**^289^LL**R**^292^   H^351^LGLGSGIHS**C**FG^363^        JX119080
  Svu021   T^247^WF**T**T^251^   **E**^281^VR**R**^284^   E^347^LIAQGGGNARTGHR**C**PG^364^   JX119081
  Svu022   G^251^HE**T**T^255^   **E**^286^TL**R**^289^   H^349^ISFGHGPHV**C**PG^361^        JX119082
  Svu023   G^238^HQP**T**^242^   **E**^276^VLW^279^       F^337^SFGHGEHRCPFPA^350^           JX119083
  Svu024   A^247^FE**T**T^251^   **E**^284^QILW^288^      S^344^HLAFSSGPHE**C**PG^357^       JX119084
  Svu025   Unidentified          Unidentified             H^50^LALGIGPHV**C**MG^62^          JX119085
  Svu026   G^249^NE**T**T^253^   **E**^287^VL**R**^290^   H^348^LALGSGPHY**C**LG^360^        JX119086
  Svu027   G^238^NE**T**T^242^   **E**^274^IV**R**^277^   H^335^LGFGGGGPHF**C**LG^348^       JX119087
  Svu028   G^284^ND**T**V^288^   **E**^322^LL**R**^325^   H^383^VSFGDGPHV**C**LG^395^        JX119088
  Svu029   A^242^HE**T**T^246^   **E**^297^TL**R**^300^   A^367^FMPFGGGPRT**C**LG^380^       JX119089
  Svu030   G^259^HE**T**T^263^   **E**^314^AM**R**^317^   A^383^WFPFGGGPRA**C**IG^396^       JX119090
  Svu031   G^499^HE**T**T^503^   **E**^545^TL**R**^548^   A^614^YLPFGIGPGPAWARSSRCGS^634^     
  Svu032   A^252^NV**T**T^256^   **E**^290^GL**R**^293^   R^351^HGAFGFGPHF**C**IG^364^       JX119091

From the Table [2](#T2){ref-type="table"}, we can find the I-helix is absent in *Svu*001(new family), and the I-helix and K-helix missing in *Svu*002 (105 L, often for hydroxylation activity) \[[@B29]\], which reflects I-helix is not absolutely essential for the CYP structure. The 2 members of CYP157 family *Svu*023 (E^276^VLW^279^)/157A and *Svu*024 (E^284^QILW^288^)/157C do not have arginine residue in K-helix like the CYP157C1 from *S. coelicolor* A3(2) having a motif E ^297^ QSLW \[[@B30]\] and the CYP157A2 and CYP157C2 from *S. avermitilis* exhibiting a ^257^EVLW motif and a ^257^EQSLW motif \[[@B26]\]. The CYP157 family proteins that lack consensus EXXR motifs but genetically are linked to their upstream conservons imply that they have functions linked to the upstream pathway(s) \[[@B30]\]. Besides, *Svu002*, *Svu018*, *Svu021*, *Svu023* and *Svu031* do not strictly follow the GXXXCXG motif of heme-binding.

Multiple alignments and phylogenetic analysis
---------------------------------------------

The phylogenetic tree of the combined CYPs of *S. virginiae* IBL14, *S. avermitilis* MA-4680, *S. venezuelae* ATCC 10712 and *Streptomyces sp.* Mg1 is presented in Figure [1](#F1){ref-type="fig"}. From Figure [1](#F1){ref-type="fig"}, we can find almost of all the CYPs in *S. virginiae* IBL14 are closely related to their homologues. More than 10 of CYPs from *S. virginiae* IBL14 are close to those from *Streptomyces sp.* Mg1 and the member (*Svu*001) of new CYP family found in *S. virginiae* IBL14 is only close to *Streptomyces sp.* Mg1. These results indicate that the CYPs from *S. virginiae* IBL14 are closer to those from *Streptomyces* sp. Mg1 than those from other *Streptomyces* spp, including *S. avermitilis* MA-4680 and *S. venezuelae* ATCC 10712. For the four species of *S. virginiae* IBL14, *sp*. Mg1, *avermitilis* MA-4680 and *S. venezuelae* ATCC 10712, the families CYP 107 and CYP157 (labeled with circle A and B in Figure [1](#F1){ref-type="fig"}, respectively) have more closely evolutionary relationship.

![**Phylogenetic tree of the CYPs from*S. virginiae*IBL14 and three related bacteria.** Sequences were aligned using Clustal W and the tree was calculated and constructed using MEGA 5.0. (*Streptomyces sp*. Mg1, Ssm; *S. avermitilis* MA-4680, Sam; *S. venezuelae* ATCC 10712, Sva).](1471-2164-14-130-1){#F1}

Further, the paralogous relationship of the 33 CYPs in *S. virginiae* IBL14 was generated with the neighbor-joining methods (Clustal W and MEGA 5.0). From Figure [2](#F2){ref-type="fig"}, we can find that *svh*01 and *svu*03 and *svu*04 as well as *svu*022 and *svu*005 in *S. virginiae IBL14* have the closest homologous evolutionary relationship, respectively. It's worth noting that most members belonging to the same CYP family are clustered together as expected, e.g., the 11 members of CYP107 family.

![**A paralogous tree of all CYP sequences from*S. virginae*IBL14.**](1471-2164-14-130-2){#F2}

The prediction of functions of CYPs in *S. virginiae* IBL14
-----------------------------------------------------------

A high identity over 70% among different protein sequences reasonably suggests that they may hold similar function \[[@B26]\]. As shown in the Table [1](#T1){ref-type="table"}, we can find a sum of 26 CYP sequences of *S. virginiae* IBL14 have best matches to those of other *Streptomyces*, which are helpful in function prediction.

CYP105 and CYP107 are the most studied bacterial cytochromes which are associated with the degradation and biotransformation of a diverse array of xenobiotics and antibiotic biosynthesis. Analysis of CYPs sequence of *S. virginiae* IBL14 shows that there are 11 CYPs belonging to CYP107, five to CYP105, four to CYP197, three to CYP191, two to CYP157 and one to each other family, which indicates the diversity and importance of the two groups CYP105 and CYP107. The predicted functions of several putative CYPs in *S. virginiae* IBL14, combined with reported experimental evidences, were listed in Table [3](#T3){ref-type="table"}.

###### 

**Prediction of functions of several putative CYPs in*S. virginiae*IBL14**

  **ID**   **Functions**                     **Reference**
  -------- --------------------------------- ---------------------------
  Svu003   Hydroxylation & O-demethylation   \[[@B15]\]
  Svu005   N-demethylation & Hydroxylation   \[[@B31]\]
  Svh01    Hydroxylation                     \[[@B32]\] and this study
  Svu006   Hydroxylation                     \[[@B17]\]
  Svu007   Hydroxylation                     \[[@B16]\]
  Svu019   Hydroxylation                     \[[@B19]\]
  Svu021   Hydroxylation& Decarboxylation    \[[@B33]\]
  Svu022   Hydroxylation& O-dealkylation     This study

CYPs in *S. virginiae* IBL14 and their ferredoxin reductase and ferredoxin
--------------------------------------------------------------------------

The catalytic activity of CYPs depends greatly on individual ferredoxin or/and ferredoxin reductase associated with. It was reported that there are three, six and four ferredoxin reductase genes and six, nine and two ferredoxin genes in *S. coelicolor* A3 (2), *S. avermitilis* and *S. peucetius*, respectively. In *S. coelicolor* A3 (2) only CYP105D5 is arranged in an operon with a ferredoxin gene \[[@B24]\]. In *S. peucetius* CYP147F is clustered with ferredoxin reductase \[[@B27]\]. In *S. avermitilis* both CYP105P1 and CYP105D6 are clustered with ferredoxin, CYP147B1 is arranged in an operon with a ferredoxin and ferredoxin reductase, CYP105Q1 is associated in an operon containing both a ferredoxin and ferredoxin reductase, and CYP102 is fused to a P450 reductase \[[@B26]\].

Three ferredoxin reductase genes and seven ferredoxin genes are found in *S. virginiae* IBL14 after annotation of *S. virginiae* IBL14 genome. That is, the activities of many of the CYPs in *S. virginiae* IBL14 are supported by different combinations with the three ferredoxin reductases and seven ferredoxins. Also in *S. virginiae* IBL14, *svu*005 (CYP105D), *svh*01 (CYP105C) and *svu*019 (CYP124B) is found to cluster with ferredoxin *svf*03, *svf*09 and *svf*07, respectively and *svu*020 (CYP147A) clustered with ferredoxin reductase *svfr*03 and ferredoxins *svf*06. The facts suggest that the functional realization of CYPs Svu005, Svh01, Svu019 and Svu020 needs the participation of electron transfer. The result of homology analysis by Blast-searching the Genbank are listed in the Table [4](#T4){ref-type="table"}.

###### 

**Putative ferredoxin reductases and ferredoxins in*S. viginiae*IBL14 with their closest homologs**

  **ID**^**a**^                                 **Accession numbers**   **NO. nucleic acids**   **Match in the databases**^**b**^                    
  --------------------------------------------- ----------------------- ----------------------- ------------------------------------- -------------- ----
  Putative ferredoxin reductases                                                                                                                     
  *svfr*01                                      JX119052                453                     *Streptomyces sp.* C                  ZP_07290734    94
  *Streptomyces pristinaespiralis* ATCC 25486   ZP_06911868             92                                                                           
  *svfr*02                                      JX119053                463                     *Streptomyces sp.* C                  ZP_07285271    87
  *Streptomyces sp.* Mg1                        ZP_05002250             84                                                                           
  *svfr*03                                      JX119054                464                     *Streptomyces sp*. C                  ZP_07289558    94
  *Streptomyces peucetius* ATCC 27952           CAF33360                84                                                                           
  Putative ferredoxins                                                                                                                               
  *svf*03                                       JX119055                219                     *Streptomyces sp*. C                  ZP_07285090    84
  *Streptomyces viridochromogenes* DSM 40736    ZP_07308348             79                                                                           
  *svf*04                                       JX119056                1143                    *Streptomyces sp.* Mg1                ZP_04996989    83
  *Streptomyces griseoflavus* Tu4000            ZP_07315146             83                                                                           
  *svf*05                                       JX119057                234                     *Streptomyces sp.* C                  ZP_07286537    88
  *Streptomyces sp.* Mg1                        ZP_05002165             79                                                                           
  *svf*06                                       JX119058                231                     *Streptomyces peucetius* ATCC 27952   ACE73829       62
  *Streptomyces hygroscopicus subsp*            AEY87986                61                                                                           
  *svf*07                                       JX119059                600                     *Streptomyces sp.* C                  ZP_07287304    98
  *Streptomyces venezuelae* ATCC 10712          CCA56325                94                                                                           
  *svf*08                                       JX119060                315                     *Streptomyces sp.* C                  ZP_07285869    89
  *Streptomyces peucetius* ATCC 27952           ACE73824                88                                                                           
  *svf*09                                       JX119061                243                     *Streptomyces cattleya* NRRL 8057     YP_004920089   63
  *Streptomyces diastaticus*                    AAR16520                61                                                                           

^a^ The name of gene in *S. virginiae* IBL14.

^b^ Homologues searched in Genbank.

Regulatory elements and functional genes clustered with CYPs
------------------------------------------------------------

The CYPs in *S. peucetius* ATCC27952 clustered with regulatory elements were reported \[[@B27]\]. In the annotations of gene arrangement around the putative CYPs on the *S. virginiae* IBL14 chromosome, *svu*022, *svu*023 and *svu*024 were found to cluster with the genes of ATP/GTP binding proteins (having a phosphate-binding loop for energy requiring metabolic reactions) \[[@B34]\], *svu*001, *svu*015 to cluster with LysR-family transcriptional regulator (regulating a diverse set of genes, including those involved in virulence, metabolism, quorum sensing and motility) \[[@B35]\], *svu*011 to cluster with two component transcriptional regulators and LuxR family (quorum sensing signals in Gram-negative bacteria often regulated by acylated homoserine lactones) \[[@B36]\], *svu*018 to cluster with a transcriptional regulator, AraC family (transcriptional regulators having diverse functions ranging from carbon metabolism to stress responses to virulence) \[[@B37]\] and two component transcriptional regulators, LuxR family and *svu*020 to cluster with the ATP-binding protein *fbpC* and TetR-family transcriptional regulators (among bacteria with an HTH DNA-binding motif for the transcriptional control of multidrug efflux pumps, pathways for the biosynthesis of antibiotics, response to osmotic stress and toxic chemicals, control of catabolic pathways, differentiation processes, and pathogenicity) \[[@B38]\].

As described above, the CYPs in *S. virginiae* IBL14 chromosome are responsible for the transcriptional regulation of many functional genes related with primary, secondary metabolism, as well as the responses to environmental factors as expected. Besides, CYPs are clustered with other functional genes. *svh*01 is adjacent to the genes of MdlB, ABC-type multidrug transport system, ATPase and permease components, which may be involved in the transportation of substrates \[[@B39]\]. *svu*009 lies next to alcohol dehydrogenase, suggesting that *svu*009 may take part in alcohol bioconversion and biodegradation. *svu*013 is next to 4, 5-DOPA dioxygenase which is a member of the class III extradiol dioxygenase family (a group of enzymes which use a non-heme Fe (II) to cleave aromatic rings between a hydroxylated carbon and an adjacent non-hydroxylated carbon), suggesting that the combination of *svu*013 and 4, 5-DOPA dioxygenase may be responsible in biodegradation of substrates with aromatic rings. *svu*026 is adjacent to MbtH-like protein which is found in known antibiotic synthesis gene clusters \[[@B40]\]. The cholesterol oxidase ChoL from *S. virginiae* IBL14 in the bioconversion and biodegradation of diosgenin responsible for the conversion of diosgenin to diosgenone (a 4-ene-3-keto steroid) via a couple of C3-dehydrogenation and C4-5-isomerization was reported \[[@B41]\]. In *S. virginiae* IBL14 the gene encoding Svu004 (CYP105L) clusters with the genes of putative ferredoxin Svfr2 and cholesterol oxidase (ChoL), suggesting that the cytochrome P450 joins with the cholesterol oxidase ChoL to catalyze the oxidation of cholesterol and its structural analogs. In conclusion, CYPs from *S. virginiae* IBL14 may have multiple functions in secondary metabolism, including hydroxylation, dehydrogenation, ring-cleavage, transportation, etc.

Functional identification and characteristics of *svh*01 and *svu*022
---------------------------------------------------------------------

To elucidate all putative CYPs' functions in *S. virginiae* IBL14, four CYP genes of the strain IBL14 were firstly selected. Among them, the functional identities of CYP genes *Svh01*(105C1) and *svu*022 (154H) has been finished.

The cytochrome P450 Svh01 (responsible for the C25-hydroxylation of diosgenin) \[[@B32]\] belongs to the class I (prokaryotic/mitochondrial) P450 system based on a taxonomic split, in which electrons are transferred from NADPH or NADH to ferredoxin reductase and ferredoxin. Sequence analysis revealed the complete sequence of *svh*01 with ATG as the start codon has 70% G + C content. The sequence of possible ribosome-binding site is located on the upstream of *svf*09 (a coenzyme of Svh01).

Both *svh*01 and *svf*09 contain 1200 bp and 243 bp, respectively, based on sequence analysis. To obtain the expressed products of them, both *svh*01 and *svf*09 sequences were first ligated into a pET22b vector in a cluster to generate the expression plasmid pET22b-*svh*01-*svf*09 that was then cloned into *E. coli* JM109 (DE3) to form a recombinant strain *E. coli* IBL161 \[JM109 (DE3)/pET22b-*svh*01-*svf*09\]. The PCR results of *svh*01 and *svf*09 from the recombinant strain *E. coli* IBL161 were analyzed by gel electrophoresis (Figure [3](#F3){ref-type="fig"}A and B) and also confirmed by gene sequencing.

![**DNA analysis of*svh*01,*svf*09 and*svu*022 cloned from*S. virginiae*IBL14. A**, **B** and **C** are the PCR results of *svh*01, *svf*09 and *svu*022, respectively.](1471-2164-14-130-3){#F3}

The *svu*022 with a G + C content of 73% (clustering with the gene of ATP/GTP binding protein) consists of 1239 nucleotides. Similarly, the complete sequence of *svu*022 was first inserted to the shuttle plasmid pHCMC05 to form the recombinant plasmid pHCMC05-*svu*022, and then cloned in *B. subtilis* WB800N (improving the extracellular expression level of Svu022 for the analysis of enzymatic biotransformation) to produce the recombinant strain *B. subtilis* IBL 241 \[WB800N/pHCMC05-*svu*022\]. The PCR result of *svu*022 from the recombinant strain *B. subtilis* IBL 241 is shown in Figure [3](#F3){ref-type="fig"}C.

Svh01 (105C1) is a peptide of 399 amino acids, with a molecular weight of 44.04 kDa and a pI value of 4.97 estimated by the ExPASy (a computing pI/MW tool). To obtain its expressed product and study product characteristics, the recombinant strain *E. coli* IBL161 was incubated and induced. The expression of Svh01 was shown in Figure [4](#F4){ref-type="fig"}A. From the SDS-PAGE, we can find that the two distinctly additional protein bands should be Svh01 with an about MW of 44 kDa and Svf09 with an about MW of 8.0 kDa, respectively. The further functional identification of the Svh01/FcpC of *S. virginiae* IBL14, hydroxylating the C25-tertiary carbon of diosgenin to form isonuatigenone, was experimentally confirmed \[[@B32]\].

![**SDS-PAGE analysis of Svh01 and Svu022.** (**A**) Lane 1, sample from JM109 (DE3)/pET22b cells; Lane 2, sample from *E. coli* IBL161. (**B**) Lane 1, WB800N/pHCMC05 cells; Lane 2 and 3, *B. subtilis* IBL 241.](1471-2164-14-130-4){#F4}

Svu022 (154H) is a deduced protein of 412 amino acids which shares 91% identity with that in *Streptomyces sp*. Mg1. The estimation of MW and pI of SVU022 are 44.59 kDa and 5.00, respectively. Similarly, the recombinant strain *B. subtilis* IBL 241 was incubated and induced to study the product expression and its characteristics. The expressed result of Svu022 from the recombinant strain *B. subtilis* IBL 241 was shown in Figure [4](#F4){ref-type="fig"}B. The SDS-PAGE displays a distinct protein band with about MW of 45.0 kDa as expected. The further experimental results from TLC, HPLC and LC/MS indicated that the CYP Svu022 enables to biotransform β-estradiol into estriol. Figure [5](#F5){ref-type="fig"} shows the profiles of the biotransformation of β-estradiol by strains *B. subtilis* WB800N and *B. subtilis* IBL 241 in HPLC. The functional identification of the Svu005 (CYP105D) and Svu019 (CYP124B) is in progress.

![**The profiles of the transformation of β-estradiol by strain*B. subtilis*IBL 241 in HPLC. a**: standard estriol; **b**: sample from *B. subtilis* IBL 241; **c**: standard β-estradiol; **d**: sample from *B. subtilis* WB800N.](1471-2164-14-130-5){#F5}

Conclusion
==========

*S. virginiae* IBL14 contains 33 putative CYPs, 7 ferredoxins and 3 ferredoxin reductases in its 8.0 Mb linear chromosome. Most of the CYPs in *S. virginiae* IBL14 belong to the CYP107 (11 members) family and CYP105 (5 members) family. Compared phylogenetically with CYPs from 3 typical *Streptomycete* spp., *S. virginiae* IBL14 appears to be closest to those of *Streptomyces* sp. Mg1.

Further analysis showed that among all of the 33 CYPs in *S. virginiae* IBL14, three CYPs are clustered with ferredoxins, one with ferredoxin and ferredoxin reductase and three CYPs with ATP/GTP binding proteins, four CYPs arranged with transcriptional regulatory genes and one CYP locates on the upper of ATP-binding protein and transcriptional regulators as well as four CYPs associated with other functional genes involved in secondary metabolism and degradation.

The new characteristics found in CYPs from *S. virginiae* IBL14 suggest that the EXXR motif in the K-helix is not absolutely conserved in CYP157 family as reported \[[@B30]\] and I-helix not absolutely essential for the CYP structure. Particularly, one new family was found based on the CYP *svu*001 in *S. virginiae* IBL14 which shares 66% identity only to that from *Streptomyces* sp. Mg1.

Two recombinant strains *E. coli* IBL161 \[JM109 (DE3)/pET22b-*svh*01-*svf*09\] and *B. subtilis* IBL 241 \[WB800N/pHCMC05-*svu*022\] were constructed and subsequently their functions were identified, respectively. Experimental results showed that both CYP Svh01 and CYP Svu022 are two hydroxylases, capable of bioconverting diosgenone into isonuatigenone and β-estradiol into estriol, respectively.

Methods
=======

Strains and plasmids
--------------------

*S. virginiae* IBL-14 (CCTCCM 206045) \[[@B42]\] as the strain of interest was used for the Cytochrome P450 gene identification and functional analysis. *E. coli* JM109, JM109 (DE3) and *B. subtilis* WB800N were used as the host for plasmid construction and target protein expression in the functional identification of the CYPs, respectively. The vector pET22b was used for cloning and expression of genes of interest in *E. coli*. The shuttle plasmid pHCMC05 was used for the expression of target proteins in *B. subtilis* (a GRAS strain by FDA). The features of the bacterial strains and plasmids used in this study are listed in Table [5](#T5){ref-type="table"}.

###### 

Microorganisms and plasmids used in this study

  **Strains**                **Relevant properties**                                                                                                                                                          **Source**
  -------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  *Escherichia coli*                                                                                                                                                                                          
  JM109                      Cloning host, genotype:endA1, *rec*A1, *gyr*A96, *thi*, *hsd*R17 (rk^--^, mk^+^), *rel*A1, *sup*E44, (*lac-proAB*), \[F' *tra*D36, *pro*AB, *laq*I^q^ZΔM15\]                     Promega
  JM109 (DE3)                Expression host, genotype:*end*A1, *rec*A1, *gyr*A96, *thi*, *hsd*R17 (rk^--^, mk^+^), *rel*A1, *sup*E44, λ--, Δ(*lac-proAB*), \[F', *tra*D36, *pro*AB, *lac*I^q^ZΔM15\], lDE3   Promega
  *Bacillus subtilis*                                                                                                                                                                                         
  WB800N                     Secretion host with resistance to neomycin, genotype: *npr*E *apr*E *epr bpr mpr* :: *ble npr*B :: *bsr vpr wpr*A :: *hyg cm* :: *neo*; NeoR                                     Mo Bi Tec
  *Streptomyces virginiae*                                                                                                                                                                                    
  IBL14                      Wild type                                                                                                                                                                        Our lab
  Plasmids                                                                                                                                                                                                    
  pET22b                     Expression vector in *E. coli*                                                                                                                                                   Novagen
  pHCMC05                    Shuttle plasmid                                                                                                                                                                  BGSC
  pET22b-*svh*01-*svf*09     The fragment of *svh*01 and *svf*09 were digested with *Nde*I/*EcoR*Iand *EcoR*I/*Hind* Ш, respectively, and ligated into the *Nde*Iand *Hind* Ш sites of pET22b                 This study
  pHCMC05-*svu*022           The gene of *svu*022 digested with *BamH*I/*Sma*Iligated into *BamH*I/*Sma*Idigested pHCMC05                                                                                     This study

Media and cultivation
---------------------

Luria-Bertani (LB) medium was used for plasmid construction and protein expression. A final concentration of 70 μg/ml ampicillin was supplemented into the medium when *E. coli* IBL161 \[JM109 (DE3)/pET22b-*svh*01-*svf*09\] and *E. coli* IBL152 \[JM109/pHCMC05-*svu*022\] were cultivated. A final concentrations of 25 μg/ml chloramphenicol was added to the medium when *B. subtilis* IBL 241 \[WB800N/pHCMC05-*svu*022\] was cultivated. The cultivating procedure of *S. virginiae* IBL-14 has been described previously \[[@B42]\]. Diosgenin in 95% purity (J&K Chemical Ltd, China) and β-estradiol in 98% purity (J&K Chemical Ltd, China) were dissolved in anhydrous ethanol before adding into medium.

Sequencing and *in-silico* identification analyses of CYPs
----------------------------------------------------------

The *S. virginiae* IBL14 genome sequencing was performed at 454 platform (Encode Genomics Co. Ltd., Suzhou, China) for the first time (sequence data will be published step by step). All of the ORFs of this genome were predicted using glimmer3.0 and prodigal, respectively. To dig out all possible CYP gene function information in *S. virginiae* IBL14, the genome sequence of the strain was compared with the SWISSPROT, TrEMBL, KEGG databases by using Blastp and the CDD and COG databases by using Rpsblast, respectively.

The deduced amino acid sequences of the putative CYPs of *S. virginiae* IBL14 were aligned with the CYPs from *S. avermitilis* MA-4680, *S. venezuelae* ATCC 10712 and *Streptomyces sp.* Mg1 by using ClustalW \[[@B43]\]. Then the molecular evolution and phylogenetic analyses by neighbor-joining methods were carried out using MEGA5.0 \[[@B44]\]. To forecast the possible functions involved in secondary metabolism, comparison between all putative CYPs of *S. virginiae* IBL14 with those in other organisms based on homologues was done by using Blastp too.

Using the three motifs as described above as criteria, the CYP gene candidates of *S. virginiae* IBL14 were blast searched against GenBank non-redundant protein database to identify their closest bacterial homologues and tentatively distribute all of the CYPs of *S. virginiae* IBL14 into the corresponding family or subfamily \[[@B26]\]. Similar procedure was performed to the putative ferredoxin and ferredoxin reductase genes to identify their closest bacterial homologues.

Construction and cloning of expression plasmids
-----------------------------------------------

The genes of *svh*01, *svf*09 and *svu*022 from the genomic DNA of *S. virginiae* IBL14 were amplified by using PCR method (Pfu DNA Polymerase, Fermentas, Thermo Fisher Scientific Inc.) and the primers used are listed in Table [6](#T6){ref-type="table"}. The PCR products of *svh*01 and *svf*09 were digested with *Nde*I/*EcoR*Iand *EcoR*I/*Hind* III, respectively, then ligated into a pET22b vector, and finally transformed to the host bacterium *E. coli* JM109 (DE3). Similarly, the PCR product of *svu*022 was digested with *BamH*I/*Sma* I, then ligated into a shuttle plasmid pHCMC05 and finally transformed to *B. subtilis* WB800N.

###### 

The PCR primers used in this study

  **Primer**   **Primer sequence**^**a**^**(5**^**′**^**to3**^**′**^**)**   **Restriction site**
  ------------ ------------------------------------------------------------ ----------------------
  pSVH01F      GCCCCC[CATATG]{.ul}AGTGAGTCCCTCCACACCGTC                     *Nde*I
  pSVH01R      GGAG[GAATTC]{.ul}ACTTCGCGTCCCAGGTG                           *EcoR*I
  pSVF09F      CCG[GAATTC]{.ul}GGGACGCGAAGTGAGCGCGG                         *EcoR*I
  pSVF09R      CCC[AAGCT]{.ul}TTCAGGCGGAGGGTGGGCGG                          *Hind* III
  pSVU022F     CT[GGATCC]{.ul}ATGAGCTGCCCGATCGACC                           *BamH*I
  pSVU022R     CCT[AAGCTT]{.ul}TCAGGGGTGCAGGCGTACCG                         *Sma*I

^a^The underlined sequence are recognition sites of restriction enzymes and the nucleotides before it are the protected bases. All primers are designed by Primer Premier 5.0 and verified by Oligo 7.0.

Expression and analysis of target proteins
------------------------------------------

0.3 ml (inoculation ratio of 1%) of the overnight culture of *E. coli* IBL161 as seed was inoculated in 30 ml LB medium (containing 70 μg/ml ampicillin) and then cultivated at a shaking speed of 200 rpm at 37°C. The expression of target protein was induced by adding 0.2 mM IPTG when the OD value reached 0.5 \~ 0.6 at 600 nm. Then the culture was continuously cultivated for another 24 h at 25°C at a speed of 200 rpm in a rotary shaker. Similarly, the overnight culture of *B. subtilis* IBL 241 was inoculated with 1% ratio in 30 ml LB medium (25 μg/ml chloramphenicol, 200 rpm at 30°C). After adding 0.2 mM IPTG in logarithmic growth phase, the culture was continuously cultivated for another 48 h at the same conditions. The harvested recombinant cells were resuspended and subjected to ultrasonication in 50 mM PBS (pH 7.4), and then centrifuged at 6000 rpm for 5 min. The supernatant was analysed by SDS-PAGE.

Biotransformation and product extraction
----------------------------------------

One milliliter of β-estradiol/diosgenin (a final concentration of 0.2 mg/ml) for each flask was added for biotransformation analysis after *E. coli* IBL161 was induced by IPTG at 25°C for 2 h. After cultivated for another 24 h under the same conditions, the cultures were extracted two times with a half volume of 100% ethyl acetate (Sinopharm Chemical Reagent Co., Ltd). The extracts were evaporated to dryness, then re-dissolved in 1 ml anhydrous ethanol, and finally detected and analyzed (thin layer chromatography/TLC, high performance liquid chromatography/HPLC and liquid chromatography--mass spectrometry LC-MS).

DNA and protein analytical methods
----------------------------------

DNA electrophoresis for recombinant plasmid analysis was carried out in agarose gels at 110 V for 30 min \[[@B45]\]. SDS-PAGE with a 15% (w/v) acrylamide gel for expressed protein analysis was run at 110 V for 2 h according to Schagger's publication \[[@B46]\]. The bands were visualized by Coomassie R-250 staining.

HPLC analysis of biotransformation products
-------------------------------------------

To identify and analyze the metabolites, high performance liquid chromatography (HPLC) was carried out. Simply, the sample of 10 μl was first loaded onto 250 mm Symmetry C 18 (4.6 mm × 250 mm, Waters Co., USA) and eluted with ethanol/water (60/40, v/v). The flow rate, the wavelength for UV-detection and the temperature of the column on the HPLC system (Breeze 1525 series, Waters Co., USA) were set at 1 ml/min, 245 nm and 35°C, respectively. The products after biotransformation were qualitatively and quantitatively analyzed by comparing with corresponding standard material.
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